BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36346441)

  • 21. Intravoxel incoherent motion diffusion-weighted imaging analysis of diffusion and microperfusion in grading gliomas and comparison with arterial spin labeling for evaluation of tumor perfusion.
    Shen N; Zhao L; Jiang J; Jiang R; Su C; Zhang S; Tang X; Zhu W
    J Magn Reson Imaging; 2016 Sep; 44(3):620-32. PubMed ID: 26880230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas.
    Wu CC; Jain R; Radmanesh A; Poisson LM; Guo WY; Zagzag D; Snuderl M; Placantonakis DG; Golfinos J; Chi AS
    AJNR Am J Neuroradiol; 2018 Oct; 39(10):1814-1820. PubMed ID: 30190259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis.
    Villanueva-Meyer JE; Wood MD; Choi BS; Mabray MC; Butowski NA; Tihan T; Cha S
    AJR Am J Roentgenol; 2018 Mar; 210(3):621-628. PubMed ID: 29261348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simplified perfusion fraction from diffusion-weighted imaging in preoperative prediction of IDH1 mutation in WHO grade II-III gliomas: comparison with dynamic contrast-enhanced and intravoxel incoherent motion MRI.
    Wang X; Cao M; Chen H; Ge J; Suo S; Zhou Y
    Radiol Oncol; 2020 Jun; 54(3):301-310. PubMed ID: 32559177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas.
    Zhang B; Chang K; Ramkissoon S; Tanguturi S; Bi WL; Reardon DA; Ligon KL; Alexander BM; Wen PY; Huang RY
    Neuro Oncol; 2017 Jan; 19(1):109-117. PubMed ID: 27353503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional and Volumetric Parameters for Diffusion-Weighted WHO Grade II and III Glioma Genotyping: A Method Comparison.
    Thust SC; Maynard JA; Benenati M; Wastling SJ; Mancini L; Jaunmuktane Z; Brandner S; Jäger HR
    AJNR Am J Neuroradiol; 2021 Mar; 42(3):441-447. PubMed ID: 33414227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Static
    Song S; Wang L; Yang H; Shan Y; Cheng Y; Xu L; Dong C; Zhao G; Lu J
    Eur Radiol; 2021 Jun; 31(6):4087-4096. PubMed ID: 33211141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Texture analysis- and support vector machine-assisted diffusional kurtosis imaging may allow in vivo gliomas grading and IDH-mutation status prediction: a preliminary study.
    Bisdas S; Shen H; Thust S; Katsaros V; Stranjalis G; Boskos C; Brandner S; Zhang J
    Sci Rep; 2018 Apr; 8(1):6108. PubMed ID: 29666413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined texture analysis of dynamic contrast-enhanced MRI with histogram analysis of diffusion kurtosis imaging for predicting IDH mutational status in gliomas.
    Pan T; Su CQ; Tang WT; Lin J; Lu SS; Hong XN
    Acta Radiol; 2023 Sep; 64(9):2552-2560. PubMed ID: 37331987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging.
    Lee S; Choi SH; Ryoo I; Yoon TJ; Kim TM; Lee SH; Park CK; Kim JH; Sohn CH; Park SH; Kim IH
    J Neurooncol; 2015 Jan; 121(1):141-50. PubMed ID: 25205290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic performance between MR amide proton transfer (APT) and diffusion kurtosis imaging (DKI) in glioma grading and IDH mutation status prediction at 3 T.
    Xu Z; Ke C; Liu J; Xu S; Han L; Yang Y; Qian L; Liu X; Zheng H; Lv X; Wu Y
    Eur J Radiol; 2021 Jan; 134():109466. PubMed ID: 33307459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glioma grading using multiparametric MRI: head-to-head comparison among dynamic susceptibility contrast, dynamic contrast-enhancement, diffusion-weighted images, and MR spectroscopy.
    Seo M; Choi Y; Soo Lee Y; Ahn KJ; Kim BS; Park JS; Jeon SS
    Eur J Radiol; 2023 Aug; 165():110888. PubMed ID: 37257338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis.
    Thust SC; Hassanein S; Bisdas S; Rees JH; Hyare H; Maynard JA; Brandner S; Tur C; Jäger HR; Yousry TA; Mancini L
    Eur Radiol; 2018 Sep; 28(9):3779-3788. PubMed ID: 29572636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultra high b-value diffusion weighted imaging enables better molecular grading stratification over histological grading in adult-type diffuse glioma.
    Guo J; Fu X; Li Y; Ming H; Lin Y; Yu S; Wei H; Sun C; Zhang K; Yang X
    Eur J Radiol; 2023 Nov; 168():111140. PubMed ID: 37832200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation Between Apparent Diffusion Coefficient and the Ki-67 Proliferation Index in Grading Pediatric Glioma.
    Yao R; Cheng A; Zhang Z; Jin B; Yu H
    J Comput Assist Tomogr; 2023 Mar-Apr 01; 47(2):322-328. PubMed ID: 36957971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.
    Hong EK; Choi SH; Shin DJ; Jo SW; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SH; Won JK; Kim TM; Park CK; Kim IH; Lee ST
    Korean J Radiol; 2021 Feb; 22(2):233-242. PubMed ID: 32932560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applying MAP-MRI to Identify the WHO Grade and Main Genetic Features of Adult-type Diffuse Gliomas: A Comparison of Three Diffusion-weighted MRI Models.
    Wang P; He J; Ma X; Weng L; Wu Q; Zhao P; Ban C; Hao X; Hao Z; Yuan P; Hao F; Wang S; Zhang H; Xie S; Gao Y
    Acad Radiol; 2023 Jul; 30(7):1238-1246. PubMed ID: 36347664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain T1ρ mapping for grading and IDH1 gene mutation detection of gliomas: a preliminary study.
    Cao M; Ding W; Han X; Suo S; Sun Y; Wang Y; Qu J; Zhang X; Zhou Y
    J Neurooncol; 2019 Jan; 141(1):245-252. PubMed ID: 30414094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grading of Gliomas by Using Monoexponential, Biexponential, and Stretched Exponential Diffusion-weighted MR Imaging and Diffusion Kurtosis MR Imaging.
    Bai Y; Lin Y; Tian J; Shi D; Cheng J; Haacke EM; Hong X; Ma B; Zhou J; Wang M
    Radiology; 2016 Feb; 278(2):496-504. PubMed ID: 26230975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.